Unique ID issued by UMIN | UMIN000053420 |
---|---|
Receipt number | R000060971 |
Scientific Title | Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP |
Date of disclosure of the study information | 2024/01/31 |
Last modified on | 2024/01/23 21:02:29 |
Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP
Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP
Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP
Prospective Study on the Diagnostic Efficacy of Early Gastric Cancer Using a New Thin Scope for EG-840TP
Japan |
early gastric cancer
Gastroenterology |
Malignancy
NO
To evaluate the diagnostic ability of EG-840TP in early gastric cancer and to clarify the usefulness of EG-840TP in screening.
Efficacy
Diagnosis results of Trainee and Expert
Observational
18 | years-old | <= |
Not applicable |
Male and Female
Patients undergoing endoscopic submucosal dissection (ESD) for early gastric cancer or suspected early gastric cancer.
Consent to participate in the study was obtained on paper.
Over 18 years old.
Postoperative stomach.
Patients with multiple epithelial tumors (including suspected lesions)
Patients who are judged to be inappropriate for this study by the principal investigator or subcontractor.
Patients allergic to propofol, pentazocine, and lidocaine.
Patients who are pregnant or breastfeeding.
175
1st name | tomohiro |
Middle name | |
Last name | shimada |
Sendai City Medical Center
Department of Gastroenterology
9830824
5-22-1, Tsurugaya, Miyagino-ku Sendai-shi, Miyagi-ken, Japan
0222521111
t.shimada@openhp.or.jp
1st name | Tomohiro |
Middle name | |
Last name | shimada |
Sendai City Medical Center
Department of Gastroenterology
9830824
5-22-1, Tsurugaya, Miyagino-ku Sendai-shi, Miyagi-ken, Japan
09067892904
t.shimada@openhp.or.jp
Sendai City Medical Center
none
Other
Sendai City Medical Center
5-22-1, Tsurugaya, Miyagino-ku Sendai-shi, Miyagi-ken, Japan
0222521111
t.shimada@openhp.or.jp
NO
2024 | Year | 01 | Month | 31 | Day |
Unpublished
Preinitiation
2024 | Year | 01 | Month | 10 | Day |
2024 | Year | 01 | Month | 19 | Day |
2024 | Year | 02 | Month | 01 | Day |
2025 | Year | 01 | Month | 31 | Day |
Observation procedure
The examiner uses the EG-840TP to observe the inside of the stomach before performing ESD marking operations. The ESD physician (recorder) knows the information on the target lesion that is scheduled for treatment, but does not communicate anything to the examiner other than that there is early gastric cancer or a lesion suspected of being early gastric cancer. 1, Perform intragastric screening for approximately 3 minutes using white light imaging (WLI). 2, When the area of interest is recognized, take a photo and report the area, circumference, and photo number to the recorder. After that, imaging and diagnosis using close observation: cancer (high confidence) / cancer (low confidence) / non-cancer, switching to BLI imaging and diagnosis: cancer (high confidence) / cancer (low confidence) / Report to the recorder that you are cancer-free. 3, After the observation is complete, switch to BLI and perform additional observation for about 1 minute. When an area of interest is recognized with BLI, images are taken, diagnosed, and recorded using the same procedure as above (close-up observation is performed in the order of BLI and WLI). 4, Next, the other examiner performs the examination using the method described above. In addition, for cases with odd numbered cases, the procedure will be performed in the order of Trainee and then Expert, and for even numbered cases, the procedure will be performed in the order of Expert and Trainee. 5, The recorder records the areas of interest and diagnoses pointed out by the examiner on the case record form (CRF). The final diagnosis of the region of interest is performed as follows. The day after ESD, magnified observation of the region of interest with BLI is performed using EG-760Z, and if it is diagnosed as non-cancerous (high confidence), it is considered non-cancerous. If the patient is non-cancerous (low certainty) or cancer is suspected, the diagnosis is confirmed by biopsy.
2024 | Year | 01 | Month | 23 | Day |
2024 | Year | 01 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060971
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |